Infertility and pregnancy after breast cancer: Current knowledge and future perspectives

被引:38
作者
Del Mastro, Lucia
Catzeddu, Tiziana
Venturini, Marco
机构
[1] Natl Inst Canc Res, Dept Med Oncol, I-16132 Genoa, Italy
[2] Osped Sacro Cuore Don Calabria, Dept Med Oncol, I-37024 Verona, Italy
关键词
adjuvant therapy; amenorrhea; breast cancer; infertility; latrogenic menopause; pregnancy;
D O I
10.1016/j.ctrv.2006.05.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fertility impairment induced by adjuvant treatments and potential risk associated with pregnancy, are major concerns of young pre-menopausal patients with early breast cancer. Although current evidences suggest that pregnancy does not negatively affect prognosis, a low rate (3-8%) of pregnancy after breast cancer has been reported. Among the potentiat causes of such a low rate there are a high chance of spontaneous abortions (25%) as well. as the fertility impairment induced by adjuvant treatments. No standard strategy to preserve fertility in breast cancer patients is available so far. Experimental approaches include cryopreservation strategies, and use of gonadotropin-releasing hormone (GnRH) agonists to render germinal epithelium quiescent and less sensitive to the chemotherapy cytotoxicity. Here, we reviewed current knowledge about incidence and risks of pregnancy after breast cancer, risks of ovarian failure after adjuvant treatments and experimental strategies aiming to preserve ovarian function and fertility in young breast cancer patients. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:417 / 422
页数:6
相关论文
共 47 条
[1]   Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? [J].
Aebi, S ;
Gelber, S ;
Castiglione-Gertsch, M ;
Gelber, RD ;
Collins, J ;
Thürlimann, B ;
Rudenstam, CM ;
Lindtner, J ;
Crivellari, D ;
Cortes-Funes, H ;
Simoncini, E ;
Werner, ID ;
Coates, AS ;
Goldhirsch, A .
LANCET, 2000, 355 (9218) :1869-1874
[2]  
[Anonymous], P AM SOC CLIN ONCOL
[3]  
ARIEL IM, 1989, INT SURG, V74, P185
[4]   LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST INHIBITS CYCLOPHOSPHAMIDE-INDUCED OVARIAN FOLLICULAR DEPLETION IN RHESUS-MONKEYS [J].
ATAYA, K ;
RAO, LV ;
LAWRENCE, E ;
KIMMEL, R .
BIOLOGY OF REPRODUCTION, 1995, 52 (02) :365-372
[5]  
ATAYA KM, 1985, CANCER RES, V45, P3651
[6]   Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound [J].
Bath, LE ;
Wallace, WHB ;
Shaw, MP ;
Fitzpatrick, C ;
Anderson, RA .
HUMAN REPRODUCTION, 2003, 18 (11) :2368-2374
[7]   The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. [J].
Biljan, MM ;
Hemmings, R ;
Brassard, N .
FERTILITY AND STERILITY, 2005, 84 :S95-S95
[8]   Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer [J].
Bines, J ;
Oleske, DM ;
Cobleigh, MA .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1718-1729
[9]   Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence [J].
Blakely, LJ ;
Buzdarm, AU ;
Lozada, JA ;
Shullaih, SA ;
Hoy, E ;
Smith, TL ;
Hortobagyi, GN .
CANCER, 2004, 100 (03) :465-469
[10]  
Blumenfeld Z, 2005, J Natl Cancer Inst Monogr, P40